• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种药理学特征类似于5-HT1D亚型的人类血清素受体(S12)的分子克隆。

Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype.

作者信息

Levy F O, Gudermann T, Perez-Reyes E, Birnbaumer M, Kaumann A J, Birnbaumer L

机构信息

Department of Cell Biology and Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, Texas 77030.

出版信息

J Biol Chem. 1992 Apr 15;267(11):7553-62.

PMID:1559993
Abstract

We report the molecular cloning of a fragment of human genomic DNA called S12, containing an open reading frame of 1170 nucleotides, which encodes a receptor for serotonin of 390 amino acids. The receptor function of the S12 protein was demonstrated by functional expression in mouse LS12 cells obtained by stable transfection of Ltk- cells, and LM5S12 cells, derived from LM5 cells (Ltk- cells previously transfected with the M5 muscarinic acetylcholine receptor). Adenylyl cyclase studies showed that the S12 receptor is able to mediate inhibition of adenylyl cyclase in response to serotonin in both types of cells. As studied in LM5S12 cells, the S12 receptor did not promote Ca2+ mobilization from internal stores, nor did it significantly modulate the sustained increase in [Ca2+]i elicited by stimulation of the phospholipase C stimulating M5 acetylcholine receptor. The pharmacologic profile of S12 as seen in adenylyl cyclase assays is as follows: (EC50 in nM): serotonin, full agonist (37 nM), 5-carboxamidotryptamine, full agonist (10 nM), sumatriptan, full agonist (50 nM), metergoline, partial agonist (10 nM), methysergide, partial agonist (40 nM), yohimbine, partial agonist (150 nM), metitepin, antagonist (KB = 0.7 to 1.2 nM). We propose that the human S12 serotonin receptor is a receptor of the 5-hydroxytryptamine1D subtype.

摘要

我们报道了一段名为S12的人类基因组DNA片段的分子克隆,其包含一个1170个核苷酸的开放阅读框,编码一个由390个氨基酸组成的血清素受体。通过对Ltk-细胞进行稳定转染获得的小鼠LS12细胞以及源自LM5细胞(先前用M5毒蕈碱型乙酰胆碱受体转染的Ltk-细胞)的LM5S12细胞进行功能表达,证明了S12蛋白的受体功能。腺苷酸环化酶研究表明,S12受体能够在这两种细胞中介导血清素引起的腺苷酸环化酶抑制作用。在LM5S12细胞中研究发现,S12受体既不促进细胞内钙库释放Ca2+,也不显著调节由刺激磷脂酶C的M5乙酰胆碱受体引起的细胞内Ca2+持续升高。在腺苷酸环化酶测定中观察到的S12的药理学特征如下:(以纳摩尔为单位的EC50):血清素,完全激动剂(37 nM),5-羧基色胺,完全激动剂(10 nM),舒马曲坦,完全激动剂(50 nM),麦角苄酯,部分激动剂(10 nM),美西麦角,部分激动剂(40 nM),育亨宾,部分激动剂(150 nM),美替平,拮抗剂(KB = 0.7至1.2 nM)。我们认为人类S12血清素受体是5-羟色胺1D亚型的受体。

相似文献

1
Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype.一种药理学特征类似于5-HT1D亚型的人类血清素受体(S12)的分子克隆。
J Biol Chem. 1992 Apr 15;267(11):7553-62.
2
Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase.
FEBS Lett. 1992 Jan 20;296(2):201-6. doi: 10.1016/0014-5793(92)80379-u.
3
Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.一种新型人类5-羟色胺1D受体亚型的克隆及药理学特性研究
Mol Pharmacol. 1992 Sep;42(3):439-44.
4
Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.重组人5-HT1Dα和5-HT1Dβ受体亚型在克隆细胞系中与腺苷酸环化酶抑制偶联的药理学特性:人5-HT1D亚型之间药物内在效能的明显差异。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):226-36. doi: 10.1007/BF00171052.
5
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.另一种人类血清素受体(5-HT1F)的克隆:与腺苷酸环化酶抑制作用偶联的第五种5-HT1受体亚型
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):408-12. doi: 10.1073/pnas.90.2.408.
6
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
J Neurochem. 1996 Jan;66(1):47-56. doi: 10.1046/j.1471-4159.1996.66010047.x.
7
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.阿尼地坦,一种新型5-羟色胺1D激动剂和偏头痛缓解剂:用[3H]5-羟色胺和[3H]阿尼地坦研究人5-羟色胺1Dα、人5-羟色胺1Dβ及小牛5-羟色胺1D受体的配体结合特性。
Mol Pharmacol. 1996 Dec;50(6):1567-80.
8
Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.人类S31血清素受体克隆编码一种5-羟色胺1E样血清素受体。
Mol Pharmacol. 1993 Mar;43(3):412-8.
9
Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):566-75. doi: 10.1007/BF00167231.
10
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
J Biol Chem. 1993 Nov 5;268(31):23422-6.

引用本文的文献

1
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.国际基础和临床药理学联合会。CX. 5-羟色胺受体分类:药理学与功能。
Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.
2
The 5-HT receptor - a potential target for antidepressant treatment.5-HT 受体——抗抑郁治疗的潜在靶点。
Psychopharmacology (Berl). 2018 May;235(5):1317-1334. doi: 10.1007/s00213-018-4872-1. Epub 2018 Mar 15.
3
From GTP and G proteins to TRPC channels: a personal account.
从GTP和G蛋白到瞬时受体电位通道(TRPC):个人视角
J Mol Med (Berl). 2015 Sep;93(9):941-53. doi: 10.1007/s00109-015-1328-5. Epub 2015 Sep 16.
4
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.血清素受体及其在肠易激综合征病理生理学和治疗中的作用。
Tech Coloproctol. 2014 Jul;18(7):613-21. doi: 10.1007/s10151-013-1106-8. Epub 2014 Jan 15.
5
Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence.人类5-HT(1B)受体基因中的新型及先前报道的单核苷酸多态性:与可卡因或酒精滥用或依赖无关。
Am J Med Genet. 2001 Aug 8;105(6):489-97. doi: 10.1002/ajmg.1473.
6
Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.人脑中动脉的收缩性5-羟色胺1B受体:药理学特性及免疫细胞化学定位
Br J Pharmacol. 1999 Nov;128(6):1133-40. doi: 10.1038/sj.bjp.0702773.
7
Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery.介导人脐动脉收缩的5-羟色胺受体的功能特性及信使核糖核酸表达
Br J Pharmacol. 1999 Jul;127(5):1247-55. doi: 10.1038/sj.bjp.0702647.
8
Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.重组人5-HT1Dα和5-HT1Dβ受体亚型在克隆细胞系中与腺苷酸环化酶抑制偶联的药理学特性:人5-HT1D亚型之间药物内在效能的明显差异。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):226-36. doi: 10.1007/BF00171052.
9
Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2 alpha-/-mice.Gi2α基因敲除小鼠组织和细胞中腺苷酸环化酶抑制以及G蛋白亚基表达和ADP-核糖基化模式的改变
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3209-14. doi: 10.1073/pnas.93.8.3209.
10
Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors.β1 - 肾上腺素能受体的效能低于β2 - 肾上腺素能受体。
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10798-802. doi: 10.1073/pnas.90.22.10798.